|
Dr. Arnd Kaltofen
Arnd Kaltofen is a General Partner with VI Partners and focuses on early-stage life science investments. He carries the prime responsibility for portfolio companies including Activaero, Jenavalve, Kuros Biosurgery, Oncalis and Spinelab. Prior to joining VI Partners in 2001, he built a team dedicated to venture capital transactions in the life science and health care industry for KPMG Corporate Finance. He gained his entrepreneurial experience in several medical device and health care start-ups. As MD, he started his career in a university hospital and in medical research.
Dr. Kaltofen holds an MBA from Kellogg Graduate Business School, USA and WHU Koblenz, Germany as well as a Postgraduate Degree in Computer Sciences from TU Munich, Germany.
|